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Thesis Overview
Despite the continuing decline of tuberculosis (TB) in the United States, rates of
foreign born TB continue to increase. Targeted latent tuberculosis infection (LTBI)
screening and treatment is an essential step towards the goal of decreasing foreign born
tuberculosis in the United States. Despite this goal, limited progress has been made in
understanding health care access as it relates to latent TB infection screening among the
foreign born population that develops active tuberculosis after arrival to the United
States. The goal of this thesis is to enhance current TB surveillance in order to examine
these factors and evaluate their impact on LTBI screening and delays in TB case
identification after arrival to the U.S.
This is the pilot evaluation of a new TB surveillance program implemented
through the Connecticut Department of Public Health focusing on foreign born
individuals who became TB cases following their arrival to the U.S. This enhanced
surveillance was conducted through questionnaire administration inquiring into specific
factors previously demonstrated to impact health care access and TB screening among the
foreign born. Demographic data from each case including age, location of residence, date
of arrival to U.S., TB risk factors and details of TB diagnosis were obtained from CDC
surveillance. Information was also obtained from U.S. born TB cases over the same time
to determine if general TB risk factors were relevant to the foreign born population.
Of 19 foreign-born individuals included in this evaluation, only eight reported any
previous screening for LTBI prior to eventual TB case designation, which occurred an
average 4.1 years after arrival. Those who reported prior LTBI screening were more
likely to have a routine health provider, speak their native language with their provider,
have a documented immigration status, reside in a large city and less likely to have
communication difficulties with their routine providers. Those previously screened were
more likely to have health insurance, specifically private insurance. These factors were
related to the length of time between arrival to the U.S. and TB case identification. When
compared to U.S. born cases, foreign born cases were less likely to be homeless, use
intravenous or non-intravenous drugs and consume excess alcohol. However, at this time
none of these associations were found statistically significant (p<0.05), due to the small
sample size included in this pilot evaluation. This analysis will be used to perform
evaluation of the ongoing surveillance.
Issues regarding health care access play a role in LTBI screening among foreign
born individuals after entry into the United States. In order to effectively address issues
of foreign born TB, it is essential that public health authorities and TB control programs
understand both the local epidemiology of TB among their foreign born population and
the barriers to LTBI screening and treatment among these individuals. The current
screening strategy depends having direct contact and effective communication between
health care providers and foreign born individuals. Due to a variety of factors this often
does not occur, resulting in missed opportunities for screening that would result in earlier
detection and management of latent TB infection. Efforts must be made to ensure that
these populations can access the health care system in a timely and regular manner in
order to be screened appropriately. If this cannot occur, alternative methods for targeted
LTBI screening through more proactive outreach strategies must be considered.
Background
History of Tuberculosis in the United States
As seen with other infectious diseases, there have been significant changes in the
epidemiology of tuberculosis within the United States over the past two centuries.
During the nineteenth century, TB remained a significant health burden, cited as one of
the leading causes of mortality. With improved socioeconomic conditions as well as
increased public health surveillance and prevention measures, TB-related morbidity and
mortality markedly decreased. During the 1800’s, the identification of the causative
organism, Mycobacterium tuberculosis, and the initiation of public health programs
designed to improve surveillance and control disease spread contributed to decreasing
rates of disease burden within the United States. With the development of the chest
radiograph and its use for population screening, as well as introduction of antibiotic
therapy including streptomycin in 1947 and isoniazid and pyrazinamide in 1952, TB rates
declined even further. Between 1930 and 1960 the mortality rate decreased by 92 percent
from 71 to 6 deaths per 100,000 persons.
With declining rates following the introduction of anti-mycobacterial therapy, experts
believed that TB elimination would be a reasonable goal, and in 1959 the National TB
Association began to formulate a plan to eventually eliminate the disease in the U.S.
From the 1950’s until the 1980’s TB rates continued to decline from approximately 50
cases per 100,000 population to 9.3 cases per 100,000 in 1985. Subsequently, due to
shifting commitments in public health programming and the emergence of HIV/AIDS,
federal funding for TB control programs began to decline and TB control programs
developed in the early 20th century began to disintegrate.
Consequently, the latter half of the 1980’s saw a reversal in the incidence of TB cases
detected in the United States. In 1986, there was a 2.6% increase in total number of
newly identified TB cases. With further epidemiologic investigation new high risk
groups were being identified as significant contributors to this tuberculosis resurgence in
the United States. Immunological compromise from HIV/AIDS, TB transmission in
correctional facilities and institutional settings, and a significant concentration of TB
cases among foreign born populations were identified as major factors contributing to the
increased number of cases in the U.S.3 In addition, the emergence of multidrug-resistant
TB (ie. TB resistant to isoniazid and rifampin) was detected and documented; it was
found particularly prevalent among HIV positive, incarcerated and homeless populations,
as well as within nosocomial settings.4’5 The increased number of incident TB cases as
well as identification of definable high risk populations fueled the increased attention
given to TB control efforts in the early 1990’s. During this time federal funding was
increased to educate clinicians and public health officials on TB reemergence, while also
improving TB surveillance and control efforts at the local, statewide and national levels.
Directly observed therapy became the recommended standard of care.
In 1992, TB incidence in the U.S. peaked at 26,673 cases (10.5 per 100,000 population).
From 1993 to 2005, the total number ofTB cases has declined. The rate of decline had
averaged 6.9% between the 1993 and 2002, however, this rate of decline began to
decrease beginning in 2003. This has raised some concern of slowed progress in TB
control efforts. In addition, despite the overall national rate of decline during this time
period, TB incidence has actually increased among some subpopulations, particularly the
foreign-born population residing in the United States.6
During 2004, 14,511 confirmed active TB cases (4.9 cases per 100,000 population) were
reported in the U.S., representing a 3.3% decline in incidence from 2003. Slightly more
than half (54%) of all TB cases detected were among foreign born individuals. The rate
among the U.S. born population has reached an all-time low of 2.6 cases per 100,000
population. Although the overall annual TB rate in 2004 was the lowest since national
reporting began, the rate of decline was also the smallest since 1993.7
Tuberculosis in the United States Foreign Born Population
The most recent World Health Organization reports estimate that approximately one third
of the world’s population is infected with Mycobacterium tuberculosis, the causative
organism of tuberculosis. Recent data suggests that there are approximately 8 million
new cases of active TB disease worldwide each year, causing an estimated 2 million
deaths annually. Most of the tuberculosis infections and disease related deaths occur
primarily in developing nations. In contrast, developed nations have had relatively stable
levels of infection among residents born in these countries. However, with increasing
population mobility, developed nations with substantial levels of immigration have begun
to appreciate the impact of foreign-born persons infected with tuberculosis on their
incidence and prevalence rates. This impact been previously documented throughout
areas with substantial immigration including Western Europe, New Zealand, Canada and
the United States. In each of these countries, while overall levels ofTB disease have
declined or remained nearly constant, rates of foreign born tuberculosis disease have
increased.6,9,10,11
Studies specifically targeting the epidemiology of foreign born TB in the United States
were first conducted in the early 1990’ s. At this time, the U.S. TB resurgence was being
identified and the foreign born population was recognized as having a significant
contribution to this increase. Among those individuals reported to have tuberculosis, the
proportion who were classified as foreign born increased from 21.6% (4,925 cases) in
1986 to 29.6% (7,346 cases) in 1993. By 2004, this percentage had increased to 54%
with a total of 7,806 cases of foreign born TB diagnosed in the United States. Between
1986 and 1989, the average annual active TB case rate in the foreign born population was
27.1 per 100,000 population. After 1989, the number of documented immigrants
increased greatly, largely due to individuals changing their immigration status under
provisions of the Immigration Reform and Control Act of 1986. This population was
closely screened for TB during this adjustment, and from 1990 to 1993 the incidence rate
of tuberculosis in the foreign born population increased to 33.6 per 100,000. However,
between 1993-2004, this case rate gradually declined. Most recently in 2004, it was 22.8
cases per 100,000 foreign born individuals residing in the U.S.

Additional factors were being analyzed to help characterize the foreign-born population
subgroup with elevated TB incidence, including country of origin. The top five countries
of origin during this period of immigration were Mexico, the Philippines, Vietnam, China
and Korea, each of which has native TB rates 10 to 30 times greater than those of the
United States. 3 In 2004, 25% of all foreign born individuals with TB originated from
Mexico, 11% from the Philippines and 8% from Vietnam. However, recent data from the
CDC indicates that the country of origin of foreign born individuals with TB varies
greatly throughout the United States. In 2003, the most common birth country for
reported foreign-born TB patients from California and Texas was Mexico; for New York
it was China; for Florida it was Haiti; and, for New Jersey it was India. In addition, the
length of residence in the U.S. was strongly related to the rate of TB among foreign born
individuals, with the highest rates occurring in the first five years after arrival, and over
29.6% diagnosed with tuberculosis within the first year of arrival.
Previous studies demonstrate that TB case rates were high in all age groups of foreign-
born populations, including foreign-born children. Foreign-born persons with TB were
less likely to have risk factors for TB found in the U.S. born, such as a history of
homelessness, incarceration, or excess alcohol or injection drug history. In addition,
estimates also show that less than 10% ofTB cases within the foreign born population are
associated with HIV coinfection.6
Another issue of significant concern with TB among the foreign-born residing in the
United States is the elevated levels of drug resistant TB within this subpopulation. A
review of multidrug resistant TB cases in the U.S. revealed that rates of isoniazid and
streptomycin resistance were higher for cases among foreign-born compared with US-
born patients. 4
Historically, most active TB cases among the foreign born have been attributed to a
reactivation of previous infection as opposed to a newly acquired infection following
arrival. This has been demonstrated in multiple previous studies, including major
multicenter studies of TB among the foreign born residing in San Francisco and New
York City. ’6’17 Previous studies have shown that reactivation rates are highest within 2-
5 years of immigration.6 In addition, it has been shown that within the first few years of
arrival to the U.S. TB incidence rates among foreign born populations are comparable
with their countries of origin. TM With time, the incidence of TB in foreign-born
populations declines to approach rates equivalent to the U.S. born population, also
supporting the notion that foreign born TB represents reactivation of previously, but
recently acquired infection. However, studies thus far have not clearly elicited
consistent risk factors that increase the likelihood of TB reactivation specifically among
foreign born individuals.
Tuberculosis in the Connecticut Foreign Born population
In Connecticut, TB is both physician and laboratory reportable within 12 and 48 hours of
diagnosis, respectively. All reports are made directly to the Connecticut Department of
Public Health in Hartford and to the local town of the individual’s residence. Suspect
cases include any individual on whom anti-tuberculosis therapy is initiated pending a
confirmatory diagnosis and anyone on whom a positive AFB sputum stain is obtained.
Data collected by the TB Control Program at the Connecticut Department of Public
Health demonstrates that over the past decade, overall TB incidence in Connecticut has
been progressively declining. In 1994, there were 147 reported and confirmed cases of
TB and, in 2004, the incidence decreased to 101 cases. The average annual percentage
decrease during this time was 3.2%. From 2000 to 2004, the annual TB case rate in
Connecticut averaged 3.2 per 100,000 persons, significantly below the reported national
average of 5.2 cases per 100,000 as reported in 2002.
Reflecting national epidemiologic trends of TB within the United States, one area of
developing interest and attention is the increasing number of incident TB cases among
the foreign born population residing in Connecticut. While recent data demonstrates that
the overall rate of TB in Connecticut is decreasing, the number of foreign born cases has
actually fluctuated greatly over the past 5 years.
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Between 2000 and 2004, 334 foreign born cases of tuberculosis were identified in
Connecticut. Of these, 47% were identified within the first five years after entering the
United States. A total of23% of these cases were diagnosed within their first year of
arrival, predominantly through presentation with symptoms of active disease.
Table 1. Number of Years in the United States before TB Diagnosis in Foreign-born
Persons Residing in Connecticut
Years in
<1
>9
Unknown
Total
2000
No. (%)
18 (30)
20 (33)
7(11)
11 (18)
5 (8)
61
2001
No. (%)
15 (23)
13 (20)
11 (17)
14(21)
13 (20)
66
2002
No. (%)
10(16)
10(16)
9(15)
7 (12)
25(41)
61
2003
No. (%)
21 (27)
19 (28)
12(18)
17 (25)
7(10)
78
2004
No. (%)
13(19)
19 (28)
12 (18)
17 (25)
7(10)
68
Total
No. (%)
77 (23)
81 (24)
46(14)
62(19)
68 (20)
334
Data from Connecticut Department of Public Health TB Statistics. Epidemiology ofTB in Connecticut.
http://www.dph.state.ct.us/BCH/infectiousdise/tbstatis.htm
This data illustrates that the majority of TB cases identified and diagnosed among the
foreign born are found within the first 4 years of arrival to the United States. This
demonstrates the importance of early, well targeted screening and management of LTBI
among the foreign born population in order to work towards the goal of reducing the
incidence ofTB disease in this population.
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U.S. Tuberculosis Surveillance and Case Reporting
Until the 1950’s tuberculosis surveillance had been conducted solely on a local and
regional level. However, in 1952, the United States Public Health Service TB Control
Program initiated the first national surveillance system. Since this time, the system has
undergone several changes and modifications. TB is a reportable disease in all 50 states
and all cases that are verified and meet Center for Disease Control and Prevention
surveillance case definition criteria are reported using the RVCT (Report of Verified
Case of Tuberculosis) form. This form includes patient demographic, clinical and
laboratory information from each case. The completed form is then sent to CDC to be
included in the national TB surveillance database, TRIMS (Tuberculosis Registry
Information System). Each year, the CDC publishes a report summarizing nationally
collected data for the past year and recommendations for modifications of surveillance
methods. Any additional surveillance information is collected at the individual state’s
discretion and is evaluated on a state-by-state basis to determine local epidemiology
patterns. The Division of Tuberculosis Elimination within the CDC is the group primarily
responsible for collecting and evaluating data reported by individual states regarding
incident TB cases nationally.
Through epidemiologic investigation, states have been able to identify specific needs for
TB screening in their high risk subpopulations. Some of the most common targets of
screening include the foreign born population, children, individuals infected with HIV,
those residing in correctional facilities and homeless shelters, and health care workers
exposed to TB in the healthcare setting.
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The Connecticut TB Control Program works in collaboration with health care providers
and municipal health departments to conduct surveillance for TB disease and latent TB
infection, promote screening, support and assure treatment for both latent TB infection
and active disease, and oversee contact investigations. The state reviews specific risk
factors for TB in each of the identified cases, and among foreign-born individuals,
documents date of arrival to the U.S. and country of origin.
Tuberculosis Screening of the Foreign Born Population in the United States
Based on current policy, TB screening is required for two subsets of the foreign born
population residing in the United States. The first category includes immigrants and
refugees applying for permanent legal status, and the second consists of foreign-born
individuals who entered the country on nonimmigrant visas and wish to apply for
permanent residency status. TM Immigrants and refugees who wish to enter the U.S. are
screened in their home country, most often by local physicians selected by U.S. consuls
in each respective nation. The screening procedure consists of initial chest radiologic
screening for individuals older than age 15 followed by a sputum stain for acid-fast
bacilli for people with radiographs consistent with active TB.
The four classification categories- A, B 1, B2, and B3, are designated based on the results
of the chest radiograph and sputum stain and these designations are placed on the visa
forms that all immigrants and refugees carry with them to the United States. These visa
forms are collected by the INS at international airports or border posts within the U.S.
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The information is then transferred to a CDC quarantine station, where a form is
completed and sent to the state destination for the arriving immigrant and a copy is sent
to the CDC headquarters and to the individuals themselves.
Those who have sputum that is AFB (acid-fast bacilli staining) positive are designated
class A (sputum positive), and must be treated before departure until sputum negative and
are required to visit the health department at their U.S. destination. Those with negative
smears but chest radiographs consistent with active (Class B 1) or inactive (Class B2) TB
disease are referred to health departments in their state of furore residence for further
evaluation within 30 days of their arrival to the United States, although this is on a
voluntary basis. Those with radiographs showing calcified granulomas indicative of
older, healed infection are designated Class B3, and are not referred for any further
evaluation.
The current overseas screening process has been evaluated, although published data
regarding their success from a retrospective viewpoint is rather limited. Two health
departments, Hawaii and Seattle, have collected data showing that a substantial portion of
persons for whom the initial diagnosis of TB was made within the first year after arrival
to the U.S. had entered as immigrants or refugees. In Hawaii, 78% of the 124 foreign
born persons with TB had been immigrants or refugees. In Seattle, 28 of the 48
individuals who had been in the U.S. for less that 1 year at the time of active TB
diagnosis were immigrants and refugees. In these same locations, the sensitivity of the
screening process was evaluated as well. In Hawaii, 95 (77%) of 124 immigrants for
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whom active TB was diagnosed within 1 year had been classified as B 1 (78 cases) or B2
(17 cases) or normal (29 cases) prior to arrival to the U.S. 19 Likewise, in Seattle the
corresponding number was 19 (68%) of 28 immigrants.2 Based on the relatively short
period between arrival to the U.S. and diagnosis with TB, it is speculated that the post-
immigration diagnosis is the result of a problem with overseas classification rather than
the development of new, active TB acquired after the overseas radiograph screening.
The studies from Hawaii and Seattle demonstrate that many of the new TB cases in the
foreign born occur among immigrants and refugees who participate in an overseas
screening process, but are misclassified. However, some data shows that a large
percentage of the foreign born population diagnosed with TB within one year of arrival to
the U.S. are unidentified prior to immigration. In Los Angeles County during 1993, 261
cases of TB were diagnosed among the foreign born population within one year of arrival
to the U.S. Of these, 64 (25%) were classified as B 1, 30 cases (11%) were classified as
B2 and 167 (64%) were not identified by overseas screening.21
Attempts have been made to further assess characteristics of subpopulations who are
diagnosed with TB within one year of arrival and are missed through the current
immigration/refugee screening process. A study in San Diego county showed that those
individuals with active TB screening detected through the immigration screening process
were more likely to be Asian-Pacific Islanders, born in the Philippines, while other
recently arrived undetected, foreign-born TB patients were more likely to be Hispanic
and born in Mexico. In fact, only 3% of Mexican-born TB patients residing in the U.S.
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for less than 1 year were discovered through the immigrant screening process. TB
patients identified through immigration screening were less likely to have cavities
visualized on chest radiographs and positive sputum AFB smears2.
The population of foreign born individuals undergoing screening applying for adjustment
of their immigration status has also been studied, showing a relatively high prevalence of
both TB infection and disease among this group. The Denver, Colorado department of
health reviewed its data regarding this population over a one year period. The results
showed that of 4,840 individuals tested, 2,039 (42%) had PPD tests greater than 10 mm
while 273 had evidence of TB infection by chest radiograph and 16 had sputum cultures
obtained, 4 ofwhich cultured M. tuberculosis.23
In 1998, the CDC’s Working Group on Tuberculosis Among Foreign-Born Persons
published recommendations for the prevention and control of tuberculosis among foreign
born persons. These recommendations call for specific actions to be taken by federal
agencies, state and local TB control programs, and health care providers.
The Working Group made the following recommendations:
To tailor TB-control efforts to local needs, TB-controlprograms should develop
epidemiologic profiles to identify groups offoreign-born persons in theirjurisdictions
who are at high riskfor TB Based on local epidemiologic profiles, selective screening
should be conducted amongpopulations identified as being at high riskfor TB.
Screening should target groups ofpersons who are at the highest riskfor TB infection
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and disease, accessiblefor screening, and likely to complete preventive therapy. TB-
controlprograms should direct efforts towards identifying impediments to TB diagnosis
and care among localforeign-born populations, devising strategies to address these
barriers, and maximizing activities to ensure completion oftreatment.
from Recommendations for Prevention and Control of Tuberculosis Among Foreign-Born
Persons Report of the Working Group on Tuberculosis Among Foreign-Born Persons. MMWR
Recommendations and Reports 1998 47(RR16); 1-26.
Latent Tuberculosis Infection: The Role and Challenges of Testing and
Management in the Foreign Born Population
Latent Tuberculosis Infection
When an individual is exposed to the tuberculosis bacteria- Mycobacteria tuberculosis,
the body’s immune system immediately activates a T-cell mediated response which
allows the body to fight the bacteria and prevent multiplication and disease progression.
In most cases of tuberculosis infection, the body’s immune system can adequately fight
and suppress the infection through this mechanism, causing the infection to remain quiet
or latent, contained in the body’s tissues. Once this has occurred, the body retains the T-
cells directed against the TB organism. The tuberculin skin test (TST), the Mantoux skin
test, is a standardized killed extract of cultured TB also known as purified protein
derivative, (PPD). It is injected into the skin intradermally. The resulting reaction
reflects a person’s immune response to M. tuberculosis. An immunologic response called
a delayed-type (Type IV) hypersensitivity, seen as an induration following administration
of the allergenic tuberculin protein, indicates previous exposure to the organism with
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subsequent latent tuberculosis infection (LTBI). The reaction usually begins 5-6 hours
after injection and reaches a maximum at 48-72 hours, at which time it is evaluated by a
health care provider. Based on the sensitivity and specificity of the test different cut off
points have been recommended as defining a positive reaction. For instance, individuals
who are immunosuppressed though medications or HIV are considered LTBI positive
with a 5 mm induration, while individuals with specific health issues and/or social
characteristics (including foreign born status) that place them at a high risk for TB have a
test cut off of 10 mm induration. Those individuals with no documented risk factors have
a cut-off of 15 mm.
Although latent TB is not an active disease and cannot be transmitted to others, the main
risk is that those individuals who harbor latent infection can progress to symptomatic,
active disease at any time, most commonly occurring when an individual becomes
immunocompromised for any reason. If an individual does test positive for latent
infection, additional evaluation including a chest x ray must be performed to assess for
active disease. In latent infection the chest x-ray is usually normal, but may show
abnormalities suggesting previous infection with TB such as dense pulmonary nodules or
fibrotic scarring.
Treatment of Latent TB Infection
Much work has gone into developing new manageable LTBI treatment regimens, the
current recommended treatment for latent infection is daily isoniazid (INH) for 9 months,
a course that has been deemed optimal in decreasing the risk for reactivation to active
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disease. Compliance with this therapy has become a major barrier to treatment and
although a 9 month regimen is currently preferred, the 6 month regimen of INH has been
shown to provide substantial protection and may be cost-effective in specific
circumstances. Alternative therapy regimens with shorter duration of therapy, most
notably 2 months of rifampin and pyrazinamide have been shown to be effective, as has 4
months of rifampin alone24. Regardless of the treatment decision, all cases of active
disease are reported to public health authorities and require multiple anti-mycobacterial
drug therapy and careful monitoring of treatment. Other regimens are currently under
investigation and it is anticipated that the furore will hold significant improvements in
LTBI treatment, resulting in decreased toxicity and shorter lengths of therapy.
Targeted LTBI Screening Strategies
The detection and treatment of latent tuberculosis infection stands as arguably the single,
most important intervention strategy in the elimination of tuberculosis in the United
States. Through early detection and appropriate treatment of latent infection, active TB
disease and thereby infection transmission is preventable. Recent estimates state that
approximately 10 million people in the United States have LTBI. Reducing TB rates
among the foreign born population as well as the U.S. born population can not be
achieved unless this is effectively addressed.
The identification and treatment of LTBI is a practice that has been shown to be effective
in clinical trials, although the true impact of this practice on the overall incidence of TB
has yet to be demonstrated. From a theoretical standpoint, widespread, universal LTBI
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screening and treatment should be very effective way to decrease progression to active
disease and transmission of the TB organism to others. However, through smaller scale
attempts, numerous barriers to this screening approach have been identified including
poor adherence to LTBI treatment, perceived and actual toxicity of isoniazid therapy and
difficulty of acceptance of this intervention by both health care providers and patients.
Thus, organizations such as the CDC, American Thoracic Society and Infectious
Diseases Society of America have published guidelines and outlined strategies to
carefully target LTBI screening and treatment among particularly high risk populations.2
In fact, treatment of latent TB infection remains an essential element of the TB
elimination strategy outlined by the U.S. Public Health Service Advisory Council on the
Elimination of Tuberculosis.26 The recommended approach involves identifying and
testing individuals in subpopulations at high risk for progression of latent TB to active
disease including those with medical risk factors such as HIV infection, diabetes and
chronic renal failure. Targeted testing also focuses upon individuals with epidemiologic
risk factors for M. tuberculosis infection including injection drug users and individuals
who reside in institutional settings such as correctional facilities, long term care facilities
and homeless shelters. Another identified high risk group consists of individuals
emigrating from nations with a high prevalence of TB, and as the largest of these groups,
it remains the top priority for targeted LTBI screening.
This approach places a large responsibility on TB-control agencies to identify
subpopulations of high TB risk within their jurisdictions through understanding the local
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epidemiology of TB, and developing testing initiatives to deliver care to individuals
within these groups. The epidemiologic profile should include an assessment of the risk
for LTBI as well as barriers that may exist to LTBI screening and treatment. The foreign
born population represents a group that falls into the high risk category, however, at this
time an understanding of individual immigrant groups’ health care practices and barriers
to early and effective latent TB screening and management remains very limited.
Understanding both the local epidemiology ofTB in foreign born populations as well as
barriers and factors that influence the timeliness of TB testing can provide information of
utmost importance in developing targeted and more effective screening interventions.
Special Issues Regarding TB Screening and Control in Foreign Born Populations
The U.S. foreign born population has several unique issues which have been
demonstrated to have direct impact on tuberculosis screening, diagnosis and
management. It is hypothesized that a more detailed understanding of these factors will
allow for more targeted and earlier screening, allowing for decreased infection
transmission of infection, with the expectations of declining incidence of infection with
the goal of eventual elimination of tuberculosis in the United States. Through evaluation
of the epidemiology of foreign born TB and more detailed surveillance, risk factors that
impact tuberculosis screening and delayed diagnosis can be better understood, and
appropriate interventions can be designed and implemented.
22
Health Care Access Issues
Immigrants have less access to health care and lower health care use than do their U.S.
born counterparts, as reflected in their overall health care expenditures. In 1998,
immigrants accounted for $39.5 billion in health care expenditures, with per capita health
expenditures 55% lower than those of U.S. born persons after adjustment for insurance
status and income.27
Among the foreign born population, delays in seeking care and accessing the U.S. health
care system are common, and occur for a variety ofreasons including:
1. Financial barriers and a lack of health insurance
2. Lack of routine health care
3. Language and cultural barriers between patients and providers
4. Inadequate understanding of the nature ofpreventive health care and the role of
regular disease screening
5. Concerns regarding the effects of diagnosis on various aspects of life including
employment, interactions with family and friends and fears of deportment
Financial Barriers and Lack of Health Insurance
The foreign born population represents a disproportionately large share of the U.S.
population living without any form of health insurance. Details regarding this disparity
and its impact on the public health are still being investigated. A study of residents of
Los Angeles showed that uninsured rates for the foreign-born are 24 percent higher than
those of U.S. born individuals. Differences within the foreign-born population are even
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greater with rates ofuninsured as high as 68 percent for undocumented immigrants
compared to 23 percent for citizen immigrants. The same study also elicited factors
contributing to a lack of insurance, largely socioeconomic status proxies including lower
education, household income and total assets.s
Previous studies have demonstrated that from 1989 to 1991, the foreign-born population
was twice as likely as the US-born population to lack any form of health insurance
(26.2% vs. 13.0%). A major nationwide study showed that the highest rate of uninsured
status among foreign born populations, 40.8%, was found among foreign-born Hispanics.
This same study demonstrated that persons who had lived in the United States for less
than 15 years were 1.5 to 4.7 times more likely to be uninsured than were US-born
Caucasian residents.29
The uninsured are much less likely to use services than are the privately insured, and they
pay for a larger proportion of their medical care expenses out of pocket.3 Both of these
trends have been documented within foreign born populations residing in the United
States.26 The lack of health insurance is a major issue, precluding appropriate access to
health care for preventive health services and delaying seeking care when medically
necessary. With infectious diseases such as TB and HIV disproportionately affecting
uninsured populations including immigrants, lack of health insurance and decreased
ability to pay for health care can have significant adverse public health consequences.
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Lack of Routine Health Care
Previous studies have shown that immigrants to the United States have overall less
contact with the health care system and most lack routine sources of health care. This
lack of routine care serves as a significant barrier for the provision ofpreventive health
care screening and appropriate health maintenance guidance among the foreign born
population. TB screening among this population falls under the realm of primary and, in
some cases, secondary prevention. Without routine care, tuberculin skin testing is often
delayed or not performed at all. Previous studies have demonstrated that individuals of
Hispanic origin are less likely to have a usual place of care and a usual provider, relative
to their non-Hispanic counterparts living in the same geographical area.31 Studies among
African born U.S. residents in comparison to U.S. born African-Americans have shown
that despite comparable general health stares, foreign born populations receive
appropriate primary care and routine preventive screening procedures, such as
mammography and pap smears, at much lower rates.2
More specifically, studies have demonstrated that individuals who lack routine health
care and develop active TB are more likely to delay seeing a physician following the
onset of symptoms,a3 It is hypothesized, although not yet demonstrated, that those
individuals without routine health care are less likely to receive appropriate LTBI
screening and treatment. However, at this point, the impact of routine health care on
LTBI screening and management, particularly among the foreign-born, has not been very
well studied.
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Language and Cultural Barriers between Foreign Born Persons and U.S. Health
Care Providers
Access to quality health care involves ensuring that communication between all parties
involved, particularly patients and providers, is effective. Services must be provided in a
manner that is both linguistically and culturally appropriate, without discrimination. A
study of racial and ethnic minority patients within the San Francisco Bay area showed
that there was much concern that physicians and health care staff lacked knowledge of,
and sensitivity to, challenges facing these groups. Stereotyping, lack of culturally
appropriate information materials, and intolerance of patients with limited English
speaking abilities were all cited as significant factors which would adversely impact
34patients’ abilities to seek needed care.
Language barriers have been studied as they pertain to health care access among
individuals eventually diagnosed with TB. A study of 184 New York City TB patients
identified substantial patient delays (median, 25 days) in seeking care following the onset
of tuberculosis symptoms. The reported delay was longer (median, 51 days) among
patients whose primary language was not English.3 While this study focused on active
TB disease, language issues that delay health care access among the foreign born can be
applied to TB screening among populations with high rates of TB.
Provider-patient communication has been demonstrated to have significant implications
with regard to LTBI screening and treatment. It has been demonstrated that being
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interviewed by a health-care provider with the same native language as the immigrant
patient was significantly associated with completion of screening for LTBI.36
In addition, adherence with isoniazid (INH), the medication of choice for latent TB
infection, is a major issue precluding successful management of LTBI. In the entire U.S.
population, completion rates for treatment with 9 months of INH therapy, the consensus
recommendation for treatment of latent TB infection, are generally quite low (around
30%) and these rates are significantly lower among foreign born populations. With
regard to completion of any LTBI therapy, communication is of the utmost importance,
specifically understanding the benefits of therapy, describing the numerous potential side
effects of the medications, and managing these side effects appropriately. It has been
documented that individuals with LTBI of Latino background who described themselves
as bicultural were more likely to complete their INH therapy than those who identified
themselves solely as Hispanic.a7
Concerns regarding the effects of diagnosis on various aspects of life including
employment, interactions with family and friends and fears of deportation
Although the United States is considered by many as one of the most welcoming nations
with regard to immigration policies, foreign born individuals residing in the U.S. still
harbor concerns regarding employment, developing relationships with others and fears of
deportation. Specifically, undocumented persons- (illegal border crossers and those on
visitor stares visas) might delay diagnosis and treatment because of fear of discovery and
possible deportation. In a study of Latina and Asian immigrant women, these fears of
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deportation constituted a significant, documented barrier that precludes early and routine
access to health care among this population.3s Other studies have also demonstrated that
fears of immigration authorities have a major impact in delaying care seeking among
symptomatic individuals eventually diagnosed with tuberculosis.34 In a study of foreign
born immigrants to San Francisco who developed TB disease, being a refugee was
identified as an independent predictor of failure to seek further medical evaluation in the
United States.9
Even though a relatively small percentage of immigrants feared that going to see a
physician would lead to trouble with immigration authorities, those who had symptoms
consistent with TB but who also harbored fears regarding immigration issues delayed
seeking care for more than 2 months on average. This delay poses a major public health
concern, allowing for opportunities to spread infection during this time. A 2001 study in
Texas explored tuberculosis characteristics in the foreign born population by immigration
classification status, dividing foreign born residents into 2 categories: permanent
residents, nonimmigrant visitors and undocumented residents. Results showed
significant differences between these subpopulations in multidrug resistance, HIV stares
and hospitalization course. Compared with other immigrants, more nonimmigrant
visitors were multi-drug-resistant, HIV-positive, hospitalized, and had lengthier
hospitalizations.4 The details about underlying differences in TB risk factors and
manifestations of TB disease between different immigrant populations have yet to be
fully appreciated, but are likely related to U.S. health care access and different barriers to
appropriate TB screening and treatment.
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Fears among a particularly vulnerable population, the foreign born, represent a major
barrier to timely and consistent access to health care, and thus adequate and appropriate
screening for TB. The extent of these barriers with regard to TB screening needs to be
further examined in order to design culturally appropriate and timely interventions among
foreign-born U.S. populations. The programs that will be the most successful are those
that are able to provide diagnosis, treatment, and long-term follow-up with practitioners
and staff who are aware ofthe cultural context of TB.
Evaluation of General Risk Factors for Tuberculosis Infection among the Foreign
Born Population Residing in Connecticut
Homelessness, intravenous drug use, and excessive alcohol consumption have all been
demonstrated as risk factors for increased exposure to M. tuberculosis and increased
likelihood of developing active tuberculosis among the general population.
Homelessness
Previous studies have demonstrated that there is a significantly elevated risk of exposure
to M. tuberculosis and an increased rate of infection transmission among the homeless
population.41 Research shows that homeless adults have a higher rate of asymptomatic
TB infection, active disease and multidrug resistant TB.42 Homelessness has also been
associated with delays in accessing the health care system among patients who develop
34active tuberculosis. However, despite extensive efforts to target homeless individuals,
few studies have evaluated factors that influence the timing of TB testing among the
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homeless. In addition, one subpopulation that has been neglected is the foreign-born U.S.
residing homeless population, as no comprehensive studies have evaluated the impact of
this subgroup on TB transmission. As discussed earlier, foreign born individuals who
arrive in the United States are at higher risk of harboring latent infection than their U.S.
born counterparts. When these individuals are unable to secure housing and are forced to
reside in shelters, migrant farm worker housing barracks and other close quarters, the risk
for reactivation and transmission may be significant. Studying the relationship between
homelessness and latent TB infection screening may have particular value with regard to
the foreign born population, as it may help identify a population at high risk for both
acquisition of infection (by foreign born stares) and disease transmission (through
homelessness).
Alcohol Consumption and Drug Use
The relationship between alcohol consumption and tuberculosis is complicated, and at
this time, poorly understood but many believe that the two are associated.43’44 Those who
suffer from chronic alcohol and drug abuse use are more likely to delay presentation to
health care providers both for preventive screening and following the onset of symptoms.
In addition, this population is less likely to complete an appropriate course of anti-TB
therapy. Previous studies have demonstrated an increased risk of LTBI among chronic
alcohol consumers, however, these two variables have not been examined thoroughly
while controlling for interacting comorbidities. In addition, the data is conflicting, as
some studies have shown no relationship between the development of active TB and drug
and alcohol use.45
30
Research examining the relationship between TB and alcohol consumption among the
foreign born U.S. population is particularly scant. One study among Vietnamese
immigrants demonstrated elevated rates of LTBI and elevated rates of excessive alcohol
consumption but was unable to identify significant correlations between the two
variables.46 Additionally, the impact of substance abuse on LTBI screening patterns
within both the U.S. born population and the foreign born population has not been
examined. Understanding the influence of substance abuse, including drug use and
chronic alcohol consumption among the foreign born TB population will allow more
targeted screening interventions for this high risk group.
Objectives
Understanding the Epidemiology of Foreign Born Tuberculosis in Connecticut
Based on the recommendations from the American Thoracic Society, the CDC and the
Infectious Diseases Society of America, one of the most critical initial steps in reaching
the goal ofTB control among the foreign born is to understand the epidemiology at the
local level. Identifying the spectrum of TB morbidity, the status of TB control within
communities, and the changes in these over time allows for specific strategies,
appropriate resource allocation and more targeted screening and infection management
interventions. While some other metropolitan regions have been able to perform detailed
surveillance of their foreign born populations, extensive evaluation of the foreign-born
TB population has not yet been performed in Connecticut.
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Studies performed in other cities suggest that foreign born individuals with TB may not
share the same risk factors as their U.S. born counterparts, however, the local
epidemiology may vary depending on social, cultural, and economic factors. In addition
to reviewing the demographic data collected from the foreign born population with TB,
information regarding previously documented risk factors for TB including
homelessness, IV drug use, non-IV drug use and alcohol abuse should be evaluated. This
information will assist public health authorities in Connecticut in better understanding
characteristics of the foreign born population who develops TB disease, providing the
background for designing appropriate interventions in education, screening and treatment
for this population.
Purpose and Uses of the Enhanced Surveillance
It is hypothesized that language, culture, and financial barriers are associated with missed
opportunities and delayed screening for latent TB infection resulting in the harboring of
LTBI and subsequent development of active TB. These same factors compound, and are
most likely responsible for, delayed diagnosis of active TB cases among foreign born
individuals.
Until recently, controversy regarding foreign born TB cases revolved around
distinguishing whether cases among the foreign born represented newly acquired
infection or reactivation of previously acquired infection. Newly developed surveillance
techniques using molecular epidemiologic methods including restriction fragment length
polymorphism (RFLP) fingerprinting and molecular PCR have consistently demonstrated
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that less clustering ofM. tuberculosis specimens occurs from foreign-born patients than
from U.S.-bom patients.47’48 This has been interpreted as evidence that the majority of
cases ofTB among foreign-born persons occur as a result of activation of latent infection
rather than newly acquired infection. In a landmark study conducted in New York City
and published in the New England Journal of Medicine, researchers used RFLP’s to
fingerprint 546 isolates ofM. tuberculosis, about half ofwhich belonged to a clustered
group (thus likely transmitted). The remainder were unique isolates, interpreted as
reactivation ofpreviously acquired infection. Analysis showed that people born outside
the United States were much less likely to be in the clustered group (odds ratio 0.47) and
therefore represented reactivation ofpreviously acquired strains.46 Thus, the foreign born
infections were acquired abroad and the development of TB disease after entry in the
U.S. was the result of reactivated infection.
With earlier, more targeted latent TB infection screening and appropriate management of
LTBI, progression to active, transmissible TB infection is preventable. The design and
implementation of the enhanced TB surveillance program is the initial attempt of the
Connecticut Department of Public Health to explore health care access issues among
those foreign born individuals who eventually do progress to active TB. Enhanced
surveillance can provide insight to delays and barriers to latent TB infection screening.
Through the enhanced surveillance, general health practices among this population will
be evaluated, including exploring the initial contact of foreign-born individuals with the
U.S. health care system following immigration. Understanding more about this
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experience, as well as general health ideas and practices among this community will
provide insights to identifying opportunities for earlier screening foi" latent TB infection
and for initiation of preventive therapy. The results of this surveillance will be used to
develop targeted prevention strategies eventually leading to a reduction in the number of
incident TB cases throughout the state.
The goal of this project is to create a new, enhanced, ongoing surveillance in order to
learn more about the foreign born population residing in CT that eventually develops
active tuberculosis. Specific characteristics will be examined with regard to their
influence on delaying the evaluation and diagnosis of tuberculosis and their impact on
latent tuberculosis screening within the foreign born population.
Enhanced Surveillance Objectives:
1. To explore demographic characteristics of active TB cases reported to the state of
Connecticut focusing on country of origin, location of residence and period of time
between arrival to CT and diagnosis of active TB infection;
2. To identify health care access points for foreign born individuals with tuberculosis
infection;
3. Identify barriers to health care access including language, financial, co-morbid
conditions and cultural issues and evaluate their impact on screening for and
treatment of latent TB infection;
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4. To develop specific goals to address identified risk factors for TB among the foreign
born population residing in Connecticut, and create improved screening strategies for
this population.
The new, enhanced foreign-born surveillance database will be ongoing, with continuing
implementation beyond the initial evaluation presented in this thesis. It is anticipated that
the database will be reviewed on a semi-annual basis, using the same statistical
evaluation used in this report. These results will be continuously evaluated by the TB
Control Program at the Connecticut Department of Public Health in order to learn more
about the foreign born population that develops TB. The goals are to develop specific
initiatives to implement earlier and well targeted screening of this population.
Methodology
Epidemiology of Foreign Born TB cases
Data used in the enhanced surveillance includes information from all TB cases reported
in the state of Connecticut between January, 2005 and March, 2006. It was collected
from Connecticut Department of Public Health records and surveillance databases, using
the TB-86 Tuberculosis case report form, which is the initial intake form issued by the
Connecticut Department of Public Health based on CDC case reporting guidelines (see
Appendix B). These forms are used in the initial surveillance interview of any individual
with suspected tuberculosis. Data includes demographic data such as date of birth,
ethnicity, country of origin, date of immigration, place of residence, history of drug and
alcohol use and housing status. In addition, details regarding the location ofTB infection
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(pulmonary vs. extrapulmonary) and chest x ray results were also obtained from this data
and evaluated in order to identify differences between the U.S. born and foreign born
populations. The data obtained from the reports is entered into the TRIMS (Tuberculosis
Registry Information System) database maintained by the CDC as a Report of Verified
Case of Tuberculosis (RVCT- see Appendix C). Information from both the RVCT and
the new, foreign born surveillance was merged, allowing for the creation of a new
database used in the data analysis.
For the purpose of this thesis, all patient identification was removed, including name,
home address, social security number, and date of birth. In addition, HIV stares, which is
collected in routine surveillance was not included in this evaluation for fear of subject
identification in conjunction with TB status and other demographic information. In
subsequent evaluations of the foreign born TB surveillance performed by the DPH, the
role of HIV status will be further examined.
Foreign Born Surveillance
Data Collection Instrument (see Appendix A)
The enhanced prospective surveillance incorporates existing data collected by local
health departments which has been supplemented by in-person interviews of foreign-born
persons living in Connecticut who are suspected of, or diagnosed with, TB. A structured
interview and questionnaire asked about the individual’s access to and experience with
health care and any TB prevention that may have been offered. Epidemiologic data
collected for each person described the means of diagnosis (through screening for latent
36
disease or presentation of symptoms consistent with active TB disease), time from arrival
to disease onset, diagnosis and initiation of treatment, immigration status, country of
origin, migration within the U.S., and access and barriers to care (including insurance
coverage and cultural barriers). This information was obtained pertaining to any regular
contact that each individual has had with the U.S. health care system including details
regarding the location of this contact, the reason for contact, as well as issues pertaining
to access and barriers to care, i.e., insurance and language issues.
Conduct of interview
The interviewer was the public health staff member who had usual contact with TB
patients and suspect patients. These include public health nurses and tuberculosis
epidemiologists within the Connecticut TB Control and Refugee Health programs. The
staff member arranges for an interview either at the health department, at the patient’s
home, or at another place (e.g., hospital) where privacy can be assured. If the patient
agrees to an interview, the staff member is the individual who determines whether an
interpreter or bi-lingual interviewer will be needed.
Those who say they speak English "very well" or "well" were interviewed in English; all
others have been interviewed with the assistance of an interpreter or by a bilingual
interviewer. The supplemental interview time is approximately 15 minutes. All
interviewers administering the questionnaire are familiar with procedures of
confidentiality and human subjects’ rights and have been trained according to guidelines
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established at the Department of Public Health. If the interviewer is not fluent in the
participant’s language, an interpreter is used.
Effort was made to ensure that the enhanced surveillance was conducted at the time of
the initial TB intake interview by the public health official assigned to each suspected
case. When this was not possible, the surveillance was administered on a subsequent
follow up encounter. All data obtained from the surveillance was immediately returned
to the Connecticut Department of Public Health TB Control Program and was entered
into a central database
Surveillance Population
The enhanced surveillance initiative applies to incident TB suspect cases in foreign-born
persons residing in Connecticut at the time of the medical evaluation that lead to their TB
diagnosis.
Definitions:
Case of Tuberculosis
A case ofTB is defined as one that meets CDC requirements for a Reported Verified
Case of Tuberculosis (RVCT) or health reporting requirements for a suspected or
confirmed case of active tuberculosis. Cases are identified by either laboratory or clinical
criteria. Laboratory criteria include isolation ofM. tuberculosis complex from a clinical
specimen, demonstration ofM. tuberculosis organisms from a nucleic acid amplification
test or demonstration of acid-fast staining bacilli in a clinical specimen in which culture
38
could not be obtained. Clinical criteria for case definition include evidence ofTB
infection based on a positive skin test AND signs and symptoms consistent with active
TB OR clinical evidence of current TB disease including an abnormal or unstable chest
radiograph AND current treatment with two or more anti TB medications.
Foreign born
This term applies to all individuals born outside the United States. For purposes of this
surveillance initiative, persons born in the Freely Association States (the Marshall
Islands, the Federated States of Micronesia, and Palau/Tmst Territories of the Pacific)
and American Samoa, Guam, and the Northern Marianas Islands are considered foreign
born. Persons born in the U.S. territories of Puerto Rico and the U.S. Virgin Islands will
be considered American-born and will not be included in the surveillance.
Inclusion criteria
The inclusion criteria for the new, enhanced surveillance was as follows:
Any reported suspect or verified case of TB
Born in a country outside the United States
Started on therapy or reported on or after September 1, 2005
Exclusion criteria
The exclusion criteria for the new, enhanced surveillance was as follows:
Children <18 years of age
Prisoners incarcerated at the time of the interview
39
IRB Information
IRB review
The surveillance protocol, data collection instruments, and informed consent documents
were submitted for review and approval to the University of Connecticut Health Center
Institutional Review Board. Approval for this evaluation was obtained on 12/14/2005;
IRB # 06-121-1. Formal IRB approval by the Department of Public Health was not
required as this new data will be collected and evaluated as standard public health
surveillance.
Informed consent
The enhanced TB surveillance serves an extension of the current standard surveillance
that is conducted by local health jurisdictions. Local health districts share TB
surveillance information with the state TB Control Program. The enhanced surveillance
is covered under the same assurances of confidentiality as the standard surveillance. As
this is a surveillance effort, informed consent is waived.
Monitoring and Confidentiality of Subjects
The Connecticut TB Control Program monitored the data collection to ensure that each
interviewer adhered to the protocol and that all applicable laws and regulations regarding
human subjects research have been followed.
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Confidentiality is very important for public health surveillance to protect the identity of
those who have information collected for public health purposes. All surveillance
information is confidential and is available only to authorized users. All individuals
involved in the process of data collection, data handling, or data dissemination have been
instructed in their responsibility to protect the data prior to the initiation of data
collection. Each individual has signed a form indicating that they are knowledgeable and
will abide by the confidentiality policies and procedures for that site and has attended
training to educate them on the requirements of HIPAA by which they must abide.
Statistical Analysis
Microsoft Access(R) was used for the purpose of data collection and storage, and analysis
of the data was performed using Stata(R) version 8.0 software.
Binomial logistic regression modeling was used to determine associations between
different variables and foreign born status when compared to the U.S. born individuals
during the study period. For any given variable, an odds ratio of greater than 1 is
associated with foreign born status.
Using ordered logistic regression modeling techniques, different data variables, from the
new foreign born surveillance and from the TB-86 forms were examined to identify
relationships and factors that were associated with a longer period of time between arrival
to the United States and TB diagnosis. An odds ratio greater than 1 is associated with
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increased time between immigration and TB diagnosis while an odds ratio of less than 1
is associated with decreased time between immigration and diagnosis.
Through binomial logistic regression modeling, variables from the foreign born
surveillance were evaluated to identify their relationship with previous tuberculin skin
testing prior to the workup yielding diagnosis of tuberculosis. Odds ratios have been
used to represent the odds of having previously been tested for latent tuberculosis
infection prior to the workup leading to an actual TB diagnosis. For example, an odds
ratio of greater than 1 demonstrates that a factor is associated with previous LTBI
screening.
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Results
Descriptive Data
Table 2. Frequencies of demographics and general variables and TB Risk Factors-
all Foreign Born TB Cases in Connecticut from 1/05-3/06 (n=64)
Age
Sex
Country of Origin
Previous Diagnosis ofTB
Size of current City or Town of
Origin
TB Test at Diagnosis
Major Site of Disease
Chest X Ray at Diagnosis
Chest X Ray Abnormality
Excessive Alcohol Use in Past
Year
IV Drug Use in Past Year
Non-IV Drug Use in Past Year
Homelessness in Past Year
Time between arrival to United
States and TB Diagnosis
Mean 39.07 years, range (20-81)
Male 34 (53.1%) Female 30 (46.9%)
India- 12 cases (18.75)
Peru- 5 cases (7.81)
Bosnia, Vietnam- 4 cases each (6.25)
Brazil, Columbia, Ecuador, Philippines, Poland- 3
cases each (4.68)
16 nations- 1-2 cases each
Yes 2 (3.12)
No 62 (96.88)
Small (population < 20,000) 4 (6.25)
Medium (population 20,000-50,000) 14 (21.87)
Large (population 50,000-100,000) 18 (28.13)
X-Large (population > 100,000) 28 (43.75)
Positive 42 (65.625)
Negative 6 (9.37)
Not Done 16 (25)
Pulmonary 42 (65.63)
Extrapulmonary 28 (43.75)
Normal10 (15.62)
Abnormal 53 (82.81)
Not Done 1 (1.5)
Cavitary 11 (17.18)
Noncavitary consistent with TB 35 (54.68)
Noncavitr7 not consistent with TB 7 (10.94)
Yes 5 (7.81)
No 58 (90.63)
Unknown 1 (1.5)
No 62 (96.88)
Unknown 2 (3.12)
Yes 1 (1.56)
No 61 (95.3)
Unknown 2 (3.12)
Yes 1 (1.5)
No 63 (98.5)
Less than 1 year 10 (15.63)
1-3 years 13 (20.31)
greater than 3 years 41 (64.06)
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Table 3. Health care access variables evaluated in Foreign Born Enhanced
Surveillance- includes only those individuals who completed the surveillance (n 19)
Mean Age
Interpreter Used
Routine Health Care Provider
Language used with Routine Provider
Location of Routine Health Services
Communication Difficulties with Routine
Provider
Any form of Health Insurance at time of TB
diagnosis
Type of Health Insurance
Previous LTBI screening
Immigration Status at Arrival
Immigration Status at Diagnosis
Change in Immigration Status between
Arrival and Diagnosis
32.42 years
Yes 8 (42.10 %)
No 11 (57.89)
Yes 9 (47.37)
No 10 (52.63)
Native language 4 (21.05)
English 12 (63.16)
Interpreter 2 ( 10.53)
Public Clinic/Community Health Center 5
(25.32)
Private Physician 6 (31.58)
Specialist Physician 1 (5.26)
Emergency Dept 2 (10.53)
Other 6 (31.58)
Yes 3 (15.79)
No 14 (73.68)
At times 1 (5.26)
Yes 8 (42.10)
No 10 (52.63)
Private 5 (25.32)
Medicaid 1 (5.26)
Medicare 2 (10.53)
Yes 8 (42.10)
No 10 (52.63)
Don’t Remember 1 (5.26)
Immigrant 4 (21.05)
Refugee 5 (25.32)
Student/Family Visa 3 (15.79)
Visitor 1 (5.26)
Temporary 1 (5.26)
Undocumented 5 (25.32)
Citizen 3 (15.79)
Immigrant 4 (21.05)
Refugee 3 (15.79)
Undocumented 7 (36.84)
Other/Unsure 1 (5.26)
Student/Family Visa 1 (5.26)
Yes 9 (47.37)
No 10 (52.63)
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Interview
During the surveillance period (December, 2005 April, 2006) 19 subjects met the
inclusion criteria and were included in the analysis. Surveillance was conducted through
an interpreter in eight cases, with the remaining interviews conducted in English or the
participant’s native language.
Access to Health Care
Ofthe group included in the surveillance, only nine individuals reported having a routine
health care provider. In nearly all cases this provider was physician, although two
reported receiving their primary care from a nurse or nurse practitioner. With regard to
the location of their main health care provider, six reported receiving their primary care
services from a private physician, five from a community health center or public clinic
and two from the Emergency Department at a local hospital. A small number saw a
specialist provider, most commonly an Infectious Disease physician for their routine care
services.
Twelve individuals reported that they communicate with their regular health care
providers in English, four in their native language, and two report always using an
interpreter. When asked about their experience communicating problems with their
providers, three individuals reported having significant communication problems while
14 reported that there were no problems.
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Eight people reported having some form of insurance and ten reported no insurance
coverage at the time of TB evaluation. The type of health insurance varied greatly and
included private insurance (5), Medicaid (1) and Medicare (2).
Previous LTBI Screening
Investigation into previous LTBI screening was conducted in order to identify patterns of
screening among foreign born individuals who are eventually suspected and/or diagnosed
with active TB disease. Only eight of the 19 individuals (42.10%) reported any LTBI
screening since arrival to the United States. The reasons for previous LTBI screening
included presenting with symptoms consistent with TB, possible contact with individuals
diagnosed with TB and routine screening for college entrance or employment. LTBI
surveillance based solely on risk factors (including foreign born status) without any
specific TB contacts occurred in only six cases.
Immigration Status
Immigration status, both on arrival in the U.S. and at the time ofTB case designation,
was evaluated, as was any change in immigration stares. The breakdown of immigration
stares on entry to the U.S. was as follows: Immigrant (4), Refugee (5), Student/Family
Visa (3), Visitor (1), Temporary (1) and Undocumented (5). Nine individuals in the
study (47.3%) reported a change in immigration stares between arrival to the United
States and the time of designation as a TB case.
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TB Diagnosis/Workup
Table 4. TB Evaluation Data from Foreign Born Enhanced Surveillance (n 19)
Reason for TB evaluation
If cough, length of cough
Location ofTB evaluation/diagnosis
Language spoken during evaluation
Communication problems during evaluation
Referred for Screening 4 (21.05 %)
Symptoms 11 (57.89)
Other Medical Condition 4 (21.05)
Less than 1 week 2 (16.67)
One week-Three Months 8 (66.67)
Greater than 3 months 2 (16.67)
Community Clinic 2 (10.53)
Specialist, non Pulmonary 1 (5.26)
ED 9 (47.37)
TB Clinic 3 (15.79)
English 14 (73.68)
English through Interpreter 5 (26.32)
Yes 1 (5.26)
No 16 (84.21)
At times 2 (10.53)
The conditions that led to the evaluation and eventual workup of suspected tuberculosis
included reported seeking care and being evaluated with any symptoms suggestive of TB
(11), the most common of which was cough. The duration of cough prior to presentation
to a health care provider varied, but when present most frequently lasted between one
week and three months (6).
The location where TB was investigated varied, and included local Emergency
Departments, community health centers and private physician offices. The Emergency
Department was the most common location of TB workup and diagnosis (7 cases).
Communication with healthcare providers was again explored, as details regarding the
language of communication and any communication difficulties at the time ofTB
evaluation were identified. Language of communication during the TB evaluation was
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most commonly English (14), and with a translator in the patient’s native language (5).
Only one individual reported any significant communication difficulties during these
encounters.
Demographic Data
The mean age of the enhanced surveillance cohort was 32.4 years (range 20-63).
Fourteen towns and cities in Connecticut were represented. The cohort participants
originated from 15 different nations with the most commonly represented nations being
Peru (3). In the cohort of foreign born individuals included in the enhanced surveillance
one person was homeless during the past year, one reported a history of non-IV drug use
in the past year, and five reported excess alcohol use during the past year.
Data Analysis
The analysis included in this evaluation represents a pilot evaluation of the surveillance,
serving as an illustration ofhow the foreign born TB surveillance data will be analyzed in
furore evaluations. While the sample size in this pilot evaluation (n 19) is too small to
yield particularly significant results, it is included in this thesis primarily for illustrative
purposes. Based on the data collected, preliminary conclusions will be presented
although statistical significance of the results has yet to be attained.
Predictors of prior latent TB infection screening
Data from the foreign born surveillance and the TB-86 form was used to identify factors
that predicted previous latent TB screening (through TB skin testing) among the
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population that eventually developed tuberculosis. Only 42 percent of patients included
in the sample had reported previous TB screening prior to the eventual diagnosis.
Table 5. Demographic, social and clinical characteristics and their association with
previous LTBI screening prior to TB diagnosis (n 19)
Characteristic
Having a regular health care provider
Speaking native language with regular
health care provider
Reporting Communication problems
with regular health care provider
Having any form of health insurance
Having Private health care insurance
Having a Documented immigration
status on at time of TB evaluation
Excess Alcohol Use in the Past Year
Residence in the U.S. for > 3 years
Live in a large city- population >
50,000
Odds Ratio for Previous LTBI testing
prior to TB Diagnosis (95% CI)
2.92 p 0.27 (0.44- 19.23)
p 0.16 (0.49- 73.46)
0.85 p 0.85 (0.16 4.61)
p 0.13 (0.63 31.29)
p0.35 (0.33-21.98)
p 0.08 (0.76- 93.34)
1.43 p 0.81 (.076- 16.90)
1.71 p 0.60 (0.22- 12.89)
2.65 p 0.45 (0.22- 31.35)
Those individuals who reported prior LTBI screening were more likely to have a routine
health provider (OR 2.92), speak their native language with their provider (OR 6.0), have
a documented immigration status (OR 8.4), reside in a large city (OR 2.65) and less likely
to have communication difficulties with their routine providers (OR 0.85). In addition,
those previously screened were more likely to have health insurance (OR 4.4), more
specifically private insurance (OR 2.7). Although the magnitude of the associations may
be large and potentially important, all calculated p values were less than 0.05, most likely
due to inadequate power from small sample size. Thus, no substantial conclusions can be
drawn from this pilot evaluation. Nonetheless, this serves as an illustration of the
analysis that will be performed on an ongoing basis of the foreign born surveillance.
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Time between arrival to the United States and TB Diagnosis
For the purpose of this analysis and future data collection, the time between arrival to the
United States and TB diagnosis was divided into three different categorical intervals.
The first group included individuals who were diagnosed with TB within the first year of
arrival in the United States. The second group was diagnosed between 1-3 years after
arrival while the third group was diagnosed greater than 3 years after arrival. As shown
earlier, of the 64 total cases of foreign-born TB included, 10 were diagnosed within the
first year of arrival to the United States, 13 diagnosed between years 1-3, and 41 were
diagnosed after 3 years of residing in the U.S.
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Table 6. Demographic, social and clinical characteristics and their association with
increased time between arrival to the U.S. and TB Diagnosis
Characteristic Odds Ratio for increased time between
arrival to U.S. and TB Diagnosis with p
value and (95% CI)
Total Foreign Born Cases in Connecticut- January, 2005-December, 2005 (n=64)
Live in a large city- population >
50,000
Previously Diagnosed with TB
Excess alcohol use within the past year
Pulmonary TB as Maior Site of Disease
Had a TB skin test at time of TB
evaluation
0.72 p 0.56 (.24- 2.20)
0.81 p0.87 (.07-9.99)
0.81 p0.81 (.13- 4.93)
0.65 p0.44 (.21-1.97)
0.60 p0.39 (.19- 1.93)
Foreign Born Cases included in Enhanced Surveillance- December, 2005- April,
2006 (n= 19)
Having a regular health care provider 1.69 p 0.61 (.23 12.31)
Speaking native language with regular 1.82 p 0.63 (. 16 21.04)
health care provider
Reporting Communication problems
with regular health care provider
Having any form of health insurance
Having Private health care insurance
Having a Documented immigration
status on entry to U.S.
Having a Documented immigration
status on at time of TB evaluation
Had a Change in Immigration status
since arrival
Homelessness in the past year
IV Drug Use in the past year
Have had previous LTBI screening
0.41 p0.32 (.07-2.39)
(.17-9.17)
(. 16- 21.05)
(.29- 22.34)
1.24 p 0.83
1.81 p 0.63
2.57 p 0.39
0.81 p0.84 (.11-5.95)
9.04 p 0.07 (.81- 100.91)
(.12-5.60)
(.11 -2.31)
(.23 12.31)
0.81 p 0.83
0.50 p0.38
1.69 p 0.61
Note: STATA ordinal logistic regression uses the proportional odds model. This is essentially the equivalent of two simultaneous
logistic regression models, one comparing long duration of time (> 3 years) with a combination of short (< year) and middle (1-3
years) durations, and a second comparing short duration of time with a combination of long and middle duration. Odds ratios
represent the likelihood that an individual with a characteristic (ex. routine health care) has a longer time interval between arrival to
the U.S. and TB diagnosis.
These factors, including those regarding health care access- routine health care provider,
communication with health care provider, insurance status, and immigration status were
not correlated with the length of time between arrival to the U.S. and TB case
identification. Ofparticular note, those individuals who were in the U.S. longer were
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more likely to have a change in immigration status since arrival (OR 9.04) and were more
likely to have had previous LTBI screening (OR 1.69). They were also less likely to
report communication problems with their health providers (OR 0.41). Again, despite
this associations, none reached a p value <0.05 level of significance, most likely due to
small sample size. This analysis serves as a basis for the evaluation of future data
collected in the ongoing surveillance.
General TB Risk Factors among Foreign Born TB cases in Connecticut
Data collected from all TB cases in Connecticut was analyzed to assess whether risk
factors associated with developing TB disease were different between the U.S. born and
foreign-born groups.
Table 7. Demographic, Social and Clinical Characteristics and their association with
Foreign Born Status- all TB cases in Connecticut, 2005 (n=95)
Characteristic
Homelessness during
past year
IV Drug Use within the
past year
Non-IV Drug Use within
the past year
Excess alcohol use
within the past year
Pulmonary TB as Major
Site of Disease
Had a TB skin test at
time of evaluation
Live in a large city-
population > 50,000
U.S. Born
Patients
(N 31)
23
13
Patients of
Foreign Born
Status (N 64)
41
47
Odds Ratio for Foreign Born
Status (95% CI)
0.11 p 0.05 (.01-1.06)
N/A
0.11 p0.05 (’01-1.06)
0.83 p O.Sl (.19- 3.73)
0.73 pO.51 (.29-1.85)
4.29 p<0.05 (1.74 -10.62)
21 45 1.31 p 0.562 (.53- 3.26)
This table shows the odds ratios for foreign born compared to U.S. born status having
various clinical, social and demographic characteristics among all individuals who were
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reported to the Department of Public Health as TB cases. Characteristics associated with
increased likelihood of foreign born status were having a TB skin test at the time of
diagnosis (OR 4.29, p<0.05) and living in a city with a population greater than 50,000
persons (OR 1.31). In contrast, factors not associated with foreign born status included
homelessness (OR 0.11, p=0.05), IV Drug use (no foreign born cases), Non-IV drug use
(OR 0.11, p=0.05), excess alcohol use (OR 0.83) and pulmonary disease as the major site
of infection (OR 0.73). These characteristics were all more prevalent among U.S. born
TB cases in Connecticut.
Limitations of the Pilot Evaluation
It is important to recognize that this study represents a pilot evaluation of the enhanced
foreign born TB surveillance system instituted by the Connecticut Department of Public
Health TB Control Program. This evaluation is based on a small number of individuals
who have completed the enhanced surveillance and thus conclusions are limited. As
evidenced by the values indicative of statistical significance, very few correlations and
risk factors identified are particularly strong, as the power of the evaluation is limited by
the small sample size. It is anticipated that stronger associations will be demonstrated
when the system has been operational for a longer period of time and more data is
collected. In addition, some characteristics worthy of investigation such as country of
origin, could not be sufficiently studied in this pilot evaluation due to an insufficient
number of cases. These will be examined in future review of the foreign born
surveillance data.
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Other issues must be considered when evaluating the new surveillance that relate to the
quality and accuracy of the information collected. Since the enhanced foreign born
surveillance is a new addition to current surveillance administered by DPH staff in the
TB control program, there is much variability in how the actual surveillance is
administered. While each of the staff members conducting the surveillance was informed
of the project and trained regarding the new surveillance instrument, the conduct of the
survey has not yet been evaluated or monitored by the surveillance coordinators or the
Connecticut Department of Public Health supervisors. In ongoing surveillance
consistency among surveyors is essential and thus it is recommended that each individual
administering the survey be monitored for quality assurance purposes.
Second, since the survey was newly introduced to the TB control program, there was
inconsistency in its use with all foreign born cases reported to the DPH during the
evaluation period. For example, public health nurses in Southern Connecticut were less
involved in the surveillance development and introduction, and consequently had lower
rates of administering the foreign born surveillance when indicated by the protocol. Thus
cases around the greater Hartford area, with Department of Public Health staff in close
geographical proximity, may have been disproportionately represented during the initial
pilot evaluation period. With further education and awareness of the DPH staff, the new
survey instrument will become implemented as part of routine surveillance and it is
anticipated that these discrepancies will no longer exist.
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Finally, when reviewing this evaluation of the foreign born surveillance, it is most
important to consider that this represents the initial pilot evaluation of an ongoing
surveillance project to provide insight into characteristics of the foreign born population
with TB residing in Connecticut. It is anticipated that this surveillance will continue into
the future and will be evaluated continuously for quality control by members of the TB
Control Program at DPH. Formal data review by the program will occur on a regular
basis in a similar manner with the same analysis as performed in this evaluation with the
goals of designing and implementing new TB screening initiatives based on the
information and results elicited.
Discussion
This thesis is the initial evaluation of three separate but related components designed to
provide a more in-depth understanding of risk factors associated with TB, missed and
delayed LTBI screening opportunities, and details regarding the medical evaluation
leading to TB diagnoses among the foreign born population residing in Connecticut.
Data was collected from the nationwide surveillance compiled in the CDC TRIMS
database, as well as the new enhanced foreign born TB surveillance developed by the
author and the TB Control Program at the Connecticut Department of Public Health.
The data from the foreign born surveillance provides some insight into the demographic
characteristics of the population, specifically focusing on issues related to limitations and
barriers to health care access for this vulnerable and underserved population. The results
show that only a small percentage of this population has any source of regular health care
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and less than half of this group has any form of health insurance. Among those with
regular providers, less than 25% of this population speak to providers in their native
languages and some report that this communication is fraught with difficulties.
It is worthwhile to note that in nearly 90% of cases included in the enhanced surveillance,
the actual workup leading to the diagnosis of TB disease did not occur in a primary care
setting. Most commonly the workup occurred in a hospital Emergency Department.
Surprisingly, language differences between patient and providers (25 % of cases) and
communication difficulties (5.26%) were reported in relatively few of these clinical
encounters. In this evaluation of the enhanced surveillance, details regarding events
leading up to these encounters including referrals and involvement of routine health care
providers, factors influencing decisions to pursue evaluation and overall satisfaction were
not assessed.
One important goal in the evaluation was to examine the characteristics of the foreig
born population that went on to develop active tuberculosis, focusing on factors that may
have influenced whether or not an individual had been previously screened for latent TB
infection. As mentioned earlier, one of the keys to reducing and eliminating t.he disease
burden of foreign-born TB is early and effective screening and treatment of LTBI. When
LTBI is diagnosed and effectively treated, active, infectious tuberculosis disease is
prevented.
What may be noteworthy is the impact that health care access issues appear to have on
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latent TB infection screening among the foreign born population that eventually develops
TB disease. Those individuals who reported any LBTI screening prior to the workup that
led to their definition as a case of TB were more likely to have a regular health care
provider, speak their native language with their provider, have any form of health
insurance, and have had a documented immigration status of any form (as opposed to
undocumented or visitor status) on arrival to the United States. Those individuals who
reported being screened for LTBI prior to the evaluation resulting in diagnosis were also
more likely to have private insurance, and slightly less likely to report communication
problems with their routine health care providers. In addition, those individuals who
were screened for LTBI were more likely to reside in cities of >50,000 population.
Previous LTBI screening was not associated with homelessness, excess alcohol use or
duration of time in the U.S. Although these findings were not supported with the
necessary statistical significance, their identification in the small sample included in this
pilot evaluation suggests that they are worthy of further exploration. It is anticipated that
as the surveillance continues and the sample size increases these findings will become
significant and serve as the basis for stronger conclusions and recommendations.
Another dependent outcome variable examined was the time between arrival to the
United States and eventual TB case identification. As discussed earlier, previous studies
have demonstrated that nearly all cases of tuberculosis among the foreign born population
are the result of reactivation of a previously acquired infection. Thus the time between
arrival to the United States and TB diagnosis represents an extremely important interval
in which appropriate screening intervention may detect latent infection. If latent
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infection is detected and treated appropriately, the development of symptoms and TB
disease is preventable, providing benefit to the infected individual and minimizing the
risk of transmission.
Therefore, variables that are associated with an increased duration of time until case
identification should be carefully evaluated and addressed in developing screening
interventions that target foreign born populations. In this analysis, the total foreign born
population was divided into three groups- diagnosis within one year of arrival to the U.S.
(3 cases), diagnosis between 1 and 3 years (3), and diagnosis more than three years after
arrival (13). Associations between those individuals who spent a longer time in the U.S.
prior to diagnosis and specific factors regarding health care access issues were examined.
No strong relationships could be elicited, however based on calculated odds ratios alone
individuals with a longer duration oftime between arrival to the U.S and eventual
designation as TB case may have been slightly more likely to have a routine health
provider, speak their native language with the routine provider, have health insurance,
and have a documented status upon entry to the U.S. However, each these associations
were minimal and none were statistically significant (p < 0.05) with the sample included
in this pilot evaluation.
The final goal of this thesis was to evaluate general TB risk factors previously
demonstrated in U.S. born populations to identify whether or not these risk factors apply
to the foreign born population in Connecticut. The data evaluated in this analysis shows
that four major risk factors for TB- homelessness, intravenous drug use, non-IV drug use
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and excess alcohol use are not associated with foreign born TB. In fact, it was shown
that the foreign born population with TB residing in Connecticut is less likely to have
these risk factors that their U.S. born counterparts also residing in the state, a finding that
is consistent with previous studies of foreign born populations with tuberculosis
disease.46,49
Implications and Recommendations
General Comments
Although this study serves as the pilot evaluation of the new surveillance program
initiated by the Connecticut Department of Public Health, the results raise several
important health care access issues regarding LTBI screening and TB risk factors among
the foreign born population residing in Connecticut. Enhancing the statewide
surveillance system will provide more data about where the foreign born population
receives its health care and insight into the barriers that this population faces.
Consequently, LTBI screening initiatives can be targeted towards specific needs of this
group.
As hypothesized, communication between health care providers and patients was shown
to be associated with latent TB infection screening among the foreign born. Those
individuals who communicated with their providers through an interpreter and not in their
native language, as well as those who reported communication difficulties with their
health care provider were less likely to be screened for LTBI. Health departments and
TB control programs need to recognize that these language and communication barriers
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preclude effective LTBI screening, and consequently must address these factors in
designing effective interventions. Efforts must be made to ensure that communication
between providers and patients is effective, particularly in the setting of LTBI screening.
It is essential that public health officials work with health care providers, particularly
those that have significant interaction with foreign born populations, to ensure that the
importance of LTBI screening is effectively communicated. It is essential that
individuals receive health care, particularly preventive screening interventions, in a
language that they can understand. Prior to their arrival in the U.S. many foreign born
individuals may not have received preventive care, including health screenings. Thus, a
special effort must be made to explain LTBI to patients in a manner and language that is
understandable. By improving communication and decreasing language and cultural
barriers, LTBI screening rates will increase and the incidence of TB disease will
decrease. It is essential that local and state public health authorities including health
departments and TB control programs work with providers serving foreign born patients
to ensure that the recommendations for LTBI screening are being followed, and of equal
importance, are communicated to patients in a manner that is understandable.
Location of current residence was associated with previous LTBI screening. Individuals
who had been previously screened were more likely to reside in large cities. This may be
explained by the greater familiarity of providers practicing in urban settings with foreign
born health and screening issues. Those clinicians who practice in urban areas may be
more knowledgeable and adherent to the current screening guidelines, and therefore more
likely to screen foreign born individuals appropriately. It is essential that all clinicians
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and especially those who care for foreign born individuals know and follow appropriate
screening guidelines and recommendations. Through providing continuing medical
education (CME) programs TB control programs at the local and statewide level should
take responsibility for ensuring clinical competency with regard to TB screening and
monitoring.
LTBI screening was associated with time spent in the U.S. prior to diagnosis, as those
who received prior screening were more likely to have resided in the U.S. for a longer
period of time. This finding should be further explored in future studies. In addition, the
data shows that foreign born individuals who had more general TB risk factors including
previous IV drug use, homelessness and excessive alcohol use may more likely to be
identified as a TB case in a shorter period of time. This finding may provide support for
the notion that the public health system, and specifically TB screening, targets those
individuals with these traditional risk factors, with less attention given to the risk factor
of being foreign born.
Finally, it was recognized that the foreign born population that develops active TB
disease after arrival to the U.S. does not necessarily share the same TB risk factors as
those U.S. born individuals who become TB cases. This has been demonstrated in
multiple previous studies, and may be due to numerous different social, cultural, and
economic factors. However, demonstration of differences between the two groups may
suggest that the current screening methods, particularly the nationwide TRIMS
surveillance conducted by the CDC, may be inadequate in assessing the foreign born
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population. Another, separate database may be warranted, one that specifically focuses
on the foreign born population and their specific risk factors in order to explore them on a
larger scale.
Although omitted from this study due to the small sample size of the pilot evaluation, an
important additional component of the enhanced surveillance that has been instituted by
the Connecticut Department of Public Health involves acquiring specific information
about where foreign born individuals included in the sample actually receive their health
care. When the surveillance is conducted specific information is collected regarding the
details of their regular health care, including the primary provider’s name or the name
and location of the community health center or public health clinic. This information was
not evaluated as part of this study, however, it remains an invaluable component of the
enhanced surveillance program. Individuals from the Connecticut TB Control Program
will continue to collect the detailed information regarding which providers care for
foreign born patients with high TB risk. Once a provider database is assembled, TB
control program staff will directly target specific providers and/or health centers to
provide education, guidance and support for their LTBI screening and treatment efforts.
Individuals with Previous LTBI Screening
Those individuals identified in the surveillance with TB disease who report being
previously tested for LTBI infection constitute an interesting population worthy of further
comment. A percentage of individuals included in the surveillance (42.1%) were
previously screened for latent TB infection, and some (5 cases) were treated for LTBI
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prior to their eventual identification as a case of TB disease. Three individuals reported
previous LTBI screening, but were not prescribed any therapy following the test either
due to a negative test or a contraindication to therapy. The surveillance did not indicate
the specifics of their LTBI treatment regimen but did inquire as to whether or not the
individual actually received medication and completed therapy. Thus two important
issues arise and both have clinical and public health implications. Why did those
individuals who reported previous LTBI infection and who were treated with INH
eventually develop TB disease? What were the circumstances regarding the individuals
who were previously identified LTBI and not treated for LTBI who eventually developed
TB disease?
With regard to the population that has been previously treated for LTBI but eventually
developed TB disease, several possibilities should be entertained. First, it must be
reiterated that while LTBI treatment with any approved medication regimen has been
shown to be highly effective, no regimen is 100% effective in preventing the
development ofTB disease. In addition, adherence difficulties with LTBI treatment must
be acknowledged; people with LTBI are not clinically ill and may not be motivated to
complete the necessary nine months of isoniazid therapy. This again emphasizes the
importance of discussing all different regimens of LTBI therapy and through effective
communication between the patient and the health care provider, the ideal regimen can be
selected, maximizing the likelihood of adherence.
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Finally, foreign-born populations come from a variety of socio-economic backgrounds,
and those without any form of health insurance may harbor concerns regarding the
acquisition and completion of the recommended therapy. Although programs are in place
to supply for LTBI therapy at no cost to those who cannot pay, these programs are often
unrecognized by both patients and health care providers. One individual included in the
enhanced surveillance cited an inability to pay as the main reason for not completing
prescribed LTBI therapy. This underscores the importance of provider and public
education regarding the availability of LTBI therapy to those who need it.
Based on the reasons outlined above, clinicians must recognize that even those
individuals who report being previously treated for LTBI should still be considered at
risk for progression to TB disease and should be carefully evaluated based on all
appropriate risk factors.
Individuals who report being previously tested but never treated for LTBI and who
eventually develop TB disease constitute another group that raise other important
concerns regarding LTBI screening and management. While recently acquired infection
during the time period between LTBI screening and presentation of TB disease is
possible, this is less likely based on the current understanding of the epidemiology of
foreign born TB. One alternative explanation is that, despite a positive tuberculin skin
test, the health care provider who evaluated the test result made the decision not to treat
for LTBI. Perhaps, the provider had misguided beliefs regarding false positive tuberculin
skin tests following Bacillus of Calmette and Guerin (BCG) vaccine administration. In
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this case it is important to emphasize that those individuals with positive TB skin tests
should be evaluated for TB disease and treated for LTBI infection. In addition, LTBI
therapy with INH is generally not administered to individuals who have had previous
INH hepatitis or other serious adverse reactions to INH, or who have active hepatitis or
end-stage liver disease. Under these circumstances other therapies may be
recommended although the clinician must decide the overall risk-benefit of treating that
individual.
It is essential that both clinicians and public health authorities understand that simply
because an individual reports previous LTBI screening and/or treatment he or she cannot
be ruled out for the possibility of TB disease. Inquiring about whether or not a test has
been performed is not sufficient. It is critical to learn more about the circumstances of
previous TB testing, the outcome of the test and details regarding LTBI treatment before
making a clinical judgment of any individual’s risk for TB disease.
Future Directions, Goals, and Initiatives in Foreign Born TB Control
Current U.S. policy requires that individuals planning to permanently immigrate to the
United States be screened for tuberculosis disease prior to departure. However, until the
last decade little to no attention has been given to the foreign born population arriving in
the U.S. with latent TB infection. These cases currently constitute the majority of the TB
burden in most states. Recent data shows that individuals who arrive to the U.S. with
latent infection are at risk for reactivation of disease and represent a significant public
health risk.
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The pilot evaluation of the enhanced surveillance suggests that there are factors regarding
health care access among foreign born individuals residing in the U.S. that may affect the
likelihood of LTBI screening. Despite the relatively low prevalence of routine health
care among the sample cohort, having a routine health provider was associated with
previous LTBI screening among the foreign born. Similarly, individuals who lacked
health insurance were less likely to have any form of LTBI screening prior to their
eventual diagnosis. Since the analysis is still in its infancy and the sample size is
currently quite small the true significance of these results is still unclear. Nonetheless,
observations made thus far emphasize the importance of ensuring that all foreign born
individuals, regardless of social, economic, or immigration status, have some way to
access the U.S. health care system, or at a minimum, public health officials who can
provide LTBI screening. Individuals who are reluctant to seek health care or unable to
pay for screening services represent a particularly vulnerable population, and one that is
at high risk for developing TB disease. It is essential that this population be screened for
LTBI, and treated appropriately. If this group cannot be accessed at health care facilities
and traditional health care access points, alternative means must be designed to target this
group. This may include conducting LTBI screening at alternative locations through
formal, public health outreach programs. Some urban centers such as San Francisco and
New York City as well as the state ofWashington have instituted programs based in
immigrant communities that provide culturally sensitive and language specific outreach,
screening and LTBI treatment services to high risk foreign born populations.
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Health department and health care provider collaboration to expand and target LTBI
screening has been shown to effectively decrease the prevalence of TB disease among the
foreign born as well as transmission rates to U.S. born individuals. Proactive and
collaborative TB screening outreach programs should be considered by Connecticut’s
public health authorities.
For numerous reasons cited previously, the foreign born population can often be
particularly difficult to access, and subsequent limited health care access can have
significant implications with regard to LTBI screening. Thus, innovative, alternative
strategies must be developed in order to reach those individuals being missed by current
LTBI testing. Some strategies targeting LTBI screening towards subgroups of the
foreign born populations such as migrant farm workers and those enrolled in school have
been successful, yet their implementation and evaluation are still in early stages. Since a
large proportion of the foreign born population is employed by a small number of
employers and industries, employment based screening has been proposed as a possible
means to reach the foreign born for TB screening. Public health authorities may provide
incentives to employers to ensure that their foreign born employees undergo LTBI
screening and management prior to beginning employment. In certain types of
employment where TB disease could pose a major public health risk, LTBI screening
could be a mandated requirement for employment, similar to the current standard for
school entry. Additionally, recent data suggests that foreign born students who enter the
U.S. on temporary visas represent a high risk and often under-screened population. Three
individuals evaluated in the pilot evaluation of the enhanced surveillance fell into this
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category. Public health outreach efforts may be required to identify these students and
ensure that they are adequately screened prior to enrollment in any educational program.
This approach has been met with much success in several states, although at this point in
time remains implemented on a state-by-state basis.
Previous epidemiologic studies as well as ATS, CDC and IDSA guidelines have
reiterated that progress towards eliminating TB in the United States and reducing TB
among foreign born persons living in the U.S. cannot be achieved without effective
targeted testing and treatment of latent TB infection. While widespread LTBI screening
and treatment has been proposed, there are far too many barriers and costs precluding its
administration in the U.S at this juncture in time. However, groups that are at
particularly high risk for latent TB infection and its progression to transmissible TB
disease must be a top priority for screening and treatment. The foreign born population
falls into this category.
Given the changing epidemiology of foreign born TB as well as variation in immigration
patterns throughout the U.S., the responsibility for screening high risk individuals and
understanding the local epidemiology of foreign born TB must be addressed by public
health authorities at the local, regional and national levels. Local health departments and
specifically designated TB control programs must understand the local epidemiology of
foreign born tuberculosis, TB risk factors, and access to LTBI screening among their
foreign born population. In addition, health departments must be held responsible for
collecting and evaluating this information with the goal of understanding how to
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effectively reach, administer screening, and provide LTBI treatment for this population.
However, health departments frequently have difficulty accessing the high risk foreign-
bom population. Thus, communication and collaboration with local health care providers,
specifically in sites serving the foreign born population including community health
centers, Emergency Departments and private practices known to care for foreign born
individuals, is critical for the successful implementation of any new LTBI screening
strategies.
Although the enhanced foreign born surveillance program addresses some specific issues
regarding health care access and the foreign born population’s risk for the development
ofTB disease, there are many other factors which have yet to be evaluated and their
impact on LTBI screening and treatment remains poorly understood. These factors
include the often lengthy referral times for screening, long waiting times in public health
clinics and Emergency Departments, distance of screening sites from patient’s homes,
and attitudes of clinic staff towards foreign born patients of different backgrounds and
immigration status, each of which is mentioned in the ATS/CDC LTBI targeted testing
recommendations.24 In future studies it will be essential to further examine the impact of
these and other contributing factors on LTBI surveillance and treatment and how to
overcome any barriers they pose in LTBI screening and management in foreign born
populations.
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Conclusion
Understanding and effectively addressing TB in the foreign born population remains one
of the major impediments to successful control and eventual elimination ofTB in the
United States. Based on current strategies targeted LTBI screening remains at the
forefront of public health efforts in early identification and treatment of TB infection
among the foreign born. Currently there are numerous barriers that preclude effective,
targeted testing and treatment of latent TB infection in this population. Once these
barriers, particularly those preventing LTBI screening, are recognized, understood and
addressed, TB control strategies will be more effective and successful. The enhanced
surveillance of TB among the foreign-born implemented by the Connecticut Department
of Public Health is an attempt to understand these barriers in order to design improved
LTBI screening interventions. This thesis describes the background, design, pilot
evaluation and preliminary results of this surveillance, and offers recommendations for
further study and improved LTBI screening strategies. Only after LTBI screening
programs focusing on the foreign born population are effectively designed, targeted and
implemented can true progress be achieved towards TB control in Connecticut and
throughout the United States.
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Appendix A-Tuberculosis in the Foreign Born Surveillance Form
Patient Name Health District State ID
Native language
Was an interpreter used?
[-1 No
Vq Yes
Questions related to patient’s most recent ROUTINE henlth care BEFORE their TB
diagnosis. If no routine provider, questions pertain t first provider after U.S. entry.
1. Do you have a health provider whom you usually see for health care?
V1 No
l-I Yes
VI In past, no longer
2. After entering the U.S. and BEFORE your TB diagnosis did you receive a skin test?
F1 No [GO to Q. 7]
ffl Yes Year:
V1 Don’t remember
3. At the time of the TB skin test, what was the reason for seeing the provider?
[3
[3
[3
E]
[3
[3
[3
Contact to a TB case
Routine Care
Gynecological care/Pregnancy
Injury
Ill
Was told by family member or friend to go
Required for employment
Other (describe)
4. If you had a positive skin test result, were you offered treatment for TB infection?
Vq Negative TST [GO to Q. 7]
I--! No [GO to Q. 7]
if] Yes
V1 Don’t remember
5. Did you take the INH?
ffl No
Yes
V-i Don’t remember
[GO to Q. 7]
[GO to Q. 7]
6. If you did not take the medicine for TB treatment, why not?
r
D
Did not think it would help
Had BCG vaccination
Do not believe in drugs (pills)
My provider told me it was not necessary
Other (describe)
7. Where do/did you USUALLY go for health care?
H
H
Public Health Clinic (Name:
Private Doctor’s Office (Name:
Traditional/Spiritual healer (Name:
Specialist Doctor (type"
Emergency Department (Town:
Other
No usual health care
Town:
Town:
Town:
8. What type of health care provider did you USUALLY see?
Doctor
Nurse
Nurse Practitioner or Physician Assistant
Other
Don’t know/remember
9. What language did you use to speak with the provider you usually see?
V1 English
D English using an interpreter
D Your native language
10. Did you have a problem communicating with the provider you usually see?
rn No
ff] Yes
V1 At times
Questions related to when the patient was DIAGNOSED with TB.
11. When you were first diagnosed with TB, did you have health insurance or coverage?
V1 No [GO to Q. 13]
V1 Yes
F-] Unknown
12. What type of health insurance or health coverage did you have?
Private Health Insurance
Medicare
Medicaid
No Insurance
Other (describe)
13. What is the main reason that you went to the provider who told you that you had TB?
H
H
H
H
H
H
Referred by another doctor/health care provider
Symptoms
Other medical condition (not TB)
Routine exam
Immigration Screening/Exam
Other
II
1 4. If you had cough, how long was it before you saw a doctor or nurse?
No cough
Less than 1 week
1 week- 1 month
Greater than 1 month- 3 months
Greater than 3 months
1 5. Where did you find out that you had tuberculosis?
D
D
D
Community Health Clinic
Private Doctor’s office
Specialist Doctor (type"
Emergency Department (location
Tuberculosis Clinic
16. What language did the doctor or nurse use when he or she told you that you had TB?
V1 English
rl English using an interpreter
[3 Your native language
17. Did you have a language problem communicating with this provider?
[21 No
I-I Yes
I-I At times
1 8. What was/is your immigration status when /oufirst entered the U.S. and currently?
First Current
[--]4 [-4
"]7 -]7
Undocumented
Immigrant/Permanent resident
Refugee
Asylee
U.S. citizen
Spouse/minor child of legal permanent resident (visa type V)
Fianc6e or minor children of U.S. citizen (visa type K)
Student/student family visa (visa type F or M)
Work visa or family member of someone with work visa (visa type H)
Visitor (for business or pleasure) (visa type B 1 or B2)
Temporary resident/visitor (unknown visa type) [Probe]
Other (Specify)
Refused to answer
Comments:
III
Appendix B- Connecticut TB-86 Form- Tuberculosis Surveillance Report
Tubroulosl Control Pro
410 Calntol Avenue, MS #11TLVB
P.O Box 340308
Hat,ford, CT 06134-0308
ofCT Department ofPubh Halth TUBERCULOSIS SURVEILLANCE REPORT
TB-86 FORM
COMPLETE FORALL TB CASES, TB CASE SUSPECTS AND INFECTIONS
(860) 509-7722 Fax" (860) 509-7743
PATIENT’s (bAST) 0:IRT)
SSN’ REASON FOR REPORT CONTACT KNOWN YES, NAlVgE SOURCE REPORTED AT DATE OF DEATI-E
ETHNIC ORIGIN" COUNTRY OFBIRTH US ENTRY DATE. US, mSTORY OF VACCINE AND DATE?
[] WI:EI [] BLACK [] ASIAN [] mSPANIC REFUGEE? [] YES [] NO
[] AIIERICANINDIAN/ALASKANNATIVE [] NON-tlIPANIC [] YES [] NO
DIRECTI,Y OBSERVED RX BY: MANTOUX TEST DATE OF MANTOUX OF DATE LAST
PPD? RESTIVE PPD[] STATE HEALTE []O [] POSITIVE [] NOT DONE [] YES []
F- Ul
SI OF.DISEASE (.PLEASE ttECK. AT.J.,EAST. OE SITE)
[] [] LYMPHATIC; [] HC, [] AND/OR [] []
[] [] LYMPHATIC; [] LYMPHATIC; [] [] []
’STREET ADDRESS.
"# DATE COLLECD SPECIMEN TYPE
--]
1. []
[]
2. []
[]
[]
[]
[]
[]
[]
[] [] (+)
[] []
[] [] (+) MTB
[] []
"PROU ’I’B" IF YES, .rF-.AR: [] [][] [] []
EPISODE? [] [] []
PasK I’ACTORS
Z (C’i’tdK A"*TAPYi WH
[] []
[] []
[] []
[]
CORRECTIONS? [] []
YES,
[]
[]
[]
[]
[]
[]
DIAGNOSED LNG-
FACILITY? [] []
YES,
[]
[]
[]
[] AICOHOL/DRUG
[]
El
[]
EMPLOYER/SCHOOL
PLOYER/SCHO
PATIENT?
[] [] []
[] [] []
DRUOS?
[] [] []
ALCOHOL?
[]YES [].0 []UNKNOWN
Y CAT SCAN TREATMENT MEDICAL SUPERVISIONPATIENT CHART NO
TELEPHONE
PITALIZED?
[] []
BEEPER/PAGER NO
HOSPITAL
ATTENDING PHYSICIAN.
PI’SICIAN CONTRq-OINO TB SuPERvIsION’
TELEPHONE:
mcn_TY
TELEPHONE DATE TNS REPORT
[] o.L [] OT DONE
[] ABNORMAL [] UNKNOWN
IF ABNORMAL
[] CAVITARY
[] NONCAVIARY
CONSISTENT WITH DISEASE
[] NONCAVITARY, NOT
C,ONSISTEN TB DISEASE
DATE;
CAT SCAN RESULTS.
[] NORMAL [] NOT DONE
[] PZA
[] EMB
[] B
[] OTI:R
EXPECTED
DURATION:
DISCmUCe/TAT:"NT
ST STA:OC>
[]YS [] NO
ONCOMPDETING THIS REPORT"
MAIL WHITE STATE HEALTH DEPARTMENT, LOCAL HEALTH DEPARTMENT, PINK FILE
IV
Appendix C- CDC Intake Form for a Report of Verified Case of Tuberculosis
Patient’s Name:
(Last)
Street Address:
REPORT OF VERIFIED CASE
(first) tM OF TUBERCULOSIS
(hh;rntJer ,trPut, Pity 1alP; Zip Codt,’}
DEPARTMENT OF HEALTH & HUMAN SERVICE8
PUBLIC HEALTH SERVICE
l@J:liIlJle1g CFN FRS FO DISFASF CONTROlAND PREVENTION (CDC)
ATLANTA, GEOROIA 3036
Exp
Spec," Number:
3. Date Submitted: By:
Me Day Y
Month’Year Reported:
Me Yr
Date of Brth:
6. I’nth-;C’ea’r Counted:
Me
8. Sexl 9:’"Et hni’’i’ty:
Day
Female Latlno
Country of Origin:
Zp Code
10. Rac: Amencan Indian(Sdect
-
el Alaska Native
more;’ [-- Asmn Spec#y (Optional)
Address for Case Counting:
Wthm City Limits 1L--] Yes 2[-] No
Blk Afncan Amencan [--] Whle
NaUve HawaHan
Olher Pacfm I.slander
Spec#y (Optional):
-14. Previous Diagnosis
of Tuberculosis:
dagnosls
F--1 If than previous
episode, check here
Sputum smear:
1 Positive 31J Not Done
Negative Unknown
15’ Major Site of Disease:
0[ Pulmonary 3[2] Lymphatic Other
10[---] Pleur-al :29I Lymphatic Unknown
[ Lymphatic Cervical 30D Bone and/or Joint
2l Lymphatic" ,ntrathoracic 0[ Genitourinary
16. Additional Site of Disease:
00[--] Pulmonary 3[ Lymphatic. Other
0[--] Pleural 9D Lymphatic Unknown
1[] Lymphatic: Cervical 3OE Bone and/or Joint
2; Lymphabc Intrathoracic .40[] Genitounnary
18. Sputum Culture:
1D Positive 3 Not Done
2[ Negative g[- Unknown
’20. Culture of Tissue and Other Body Fluids:
’
Negative Unknown (see list)
22, Tuberculin (M’nit"x) Skin Test at Diagnosis:
Negtwe Unknown
If Negahve, pat=ent anergc? Yes No Unknown
[ Mdiary If site "Other",
enter anatomic[--] Meningeal code (see list)
90[ Site not Stated
;If site "Other",
enter anatomic code50 M=hary (see list)
70[] Peritoneal Ifrrloro than
additional lte, L[01 Other* ched4 Iere
19. Microscopic Exam of Tissue and Other Body Fluids:
1[--1 Positive 31 Not Done If positive, enter
? Negative .9[] Unknown (see list)
21. Chest X-Ray:
F-"] Normal F-] Abnormal [---I Not Done D Unknown
If Abnormal |1 Cav,tary /’L] Noncav,tary U Noncavitary
Consistent Not Consistent
wth TB with TB
If Abnormal [-- Stable [---] Improving
(checkone) 2[ Worsening 9[] Unknown
rep(/rtlrlg of sbmatpd cludlrlg hlng Pxlstlrlg gathP/ing ]d rnallttnlngccletng andrevewmq oqduG erson required res#ond collection dBplas endregardm thEburden aspe including suqqestons reducnq CDC, Project Road, Aanta, 30333,(0920-0026) completed this
would celleed guarantee will confidence, only
Scbn 308(d) Heal 8e,ce (42 2,12m)
L--C 72 9A REV 01/2003 -st Copy RE#-T OF VERIFIED CASE oF TI]B’C.LILOIS Page of 2’
V
REPORT OFVERIFIED CASE
OF TUBERCULOSIS
REPORT OF VERIFIED CASE OF TUBERCULOSIS
23. HIV Status: L_] .eg.tivo LJ .eused L_J Unk
2 Indeterminate D Test Done. Results Unknown
If Positive, Based -] Medical Documentabon 2[--J Patient History 9[-] Unknown
24. Homeless Within Past Year:
No
I[ 1Yes
q] Unknown
25. Resident of Correctional Facility at Time of Diagnosis: u-] No r--] Yes [--] Unknown
If Yes,
Federal I Local Ja,I 51 Other C Fac,llty
2_J State , Juven,le 9[ JUnkCorrectional Facility
26. Resident of Long-Term Care Facility at Time of Diagnosis: D No Yes [ Unknown
lfYes, 1[_ N Home 4[ Mental Health Residential Facility 6L Other Long-Term Care Faclhty
D HospCtaI-Based Famhty 5[--] Alcohol Drug Treatment Facility 9-- Unknown
D Residential Facdty
2;", Initial Drug Regimen:
YES UNh
Rifampin O[’_-J l_l ll
Py namlde ol--I 1-] 1
Ethambu,o, 0[’ 1[--] 9[-
Streptomycin O I 9C
28, Date Therapy Started:
30. Non-Injecting Drug Use Within PastYear:
0LNo
_
Yes !r--] Unknown
YES IJNK YES UNK
Ethi de oL [_-j 9[-] Amlk 0[_] [.-_-]
Ka,amycin e[ 1[-] 9[] Rifabutlne
Cyc’ oL-
__
_[_1 ,profl O[--] I-’-] [-’
Amino n 1[ 9 OtherSahcyhc Acid
29. Injecting Drug Use Within Past Year:
uNo ,Yes 9Unk
Excess Alcohol Use Within Past Year:
0No Yes 9Unk
Occupation (Check all that apply w#hm the past 24 months),
Health Care Worker L._J Migratory Ag Itural Worker 5j Not Employed within Past 24 Months
2L C Employee 4[ ]Other Occupation 9[ ]Unknown
Comments:
. ’., !’<’ s.- ,.,;PF 603 1st Copy REPORT FRIFIFD C/E JBFPCULO
VI

